Our analysis of ChIP‐seq databases of MYCN‐amplified and c‐MYC‐expressing neuroblastoma cells, suggests that both MYCN and c‐MYC can directly bind the promotor of ATP13A3, though each at different regions, and thus may regulate ATP13A3 mRNA levels. The gene discussed is MYCN; the disease is neuroblastoma.